Breaking News Instant updates and real-time market news.

GTHX

G1 Therapeutics

$28.68

0.18 (0.63%)

16:30
12/19/18
12/19
16:30
12/19/18
16:30

G1 Therapeutics trading resumes

  • 19

    Dec

GTHX G1 Therapeutics
$28.68

0.18 (0.63%)

12/19/18
RAJA
12/19/18
INITIATION
Target $66
RAJA
Strong Buy
G1 Therapeutics initiated with a Strong Buy at Raymond James
Raymond James initiated G1 Therapeutics with a Strong Buy and a $66 price target.
09/18/18
NEED
09/18/18
NO CHANGE
Target $76
NEED
Buy
G1 Therapeutics price target raised to $76 from $60 at Needham
Needham analyst Chad Messer raised his price target on G1 Therapeutics to $76 and kept his Buy rating, citing the company's announcement yesterday of amended phase 2 trial protocol for trilaciclib testing in combination with chemotherapy and Tecentrq. The analyst believes that the myelopreservation data from this trial "may help bolster the available dataset" that the company is planning to bring to the FDA in the first half of 2019 for discussion regarding a viable path to approval. Messer adds that he looks forward to the "updated data from the randomized frontline SCLC trial of trilaciclib at ESMO in October".
09/17/18
HCWC
09/17/18
NO CHANGE
Target $79
HCWC
Buy
G1 Therapeutics price target raised to $79 from $61 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for G1 Therapeutics to $79 saying the company, in his opinion, makes positive revision to its Phase 2 protocol in newly diagnosed small cell lung cancer patients. The analyst views the earlier availability of comprehensive myelopreservation data as a positive that could add substantially to discussions with regulators in early 2019. Following the announcement of the revised protocol, White has increased confidence in the approval of trilaciclib. He keeps a Buy rating on G1 Therapeutics.
09/10/18
BTIG
09/10/18
INITIATION
Target $80
BTIG
Buy
G1 Therapeutics assumed with a Buy at BTIG
BTIG analyst Thomas Shrader assumed G1 Therapeutics with a Buy rating and a price target of $80, citing the company's "unique" position of potentially developing two "best in class" CDK4/6 inhibitors - trilaciclib and lerociclib. The analyst notes that trilaciclib's positive outcomes support its efficacy and looks ahead to the 2nd line SCLC data later this year. Shrader adds that while the stock is no longer cheap, having risen nearly 400% since its IPO, "significant upside" in the stock price remains thanks to the "large market opportunity" of both programs that he estimates to be around $2B by 2025.

TODAY'S FREE FLY STORIES

CVX

Chevron

$114.79

-0.55 (-0.48%)

06:28
10/21/19
10/21
06:28
10/21/19
06:28
Periodicals
U.S. considers extension of Chevron's Venezuela waiver, Bloomberg says »

The U.S. is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AUB

Atlantic Union Bankshares

$37.68

0.37 (0.99%)

06:27
10/21/19
10/21
06:27
10/21/19
06:27
Upgrade
Atlantic Union Bankshares rating change  »

Atlantic Union Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

  • 10

    Dec

DTE

DTE Energy

$127.38

-2.11 (-1.63%)

06:26
10/21/19
10/21
06:26
10/21/19
06:26
Upgrade
DTE Energy rating change  »

DTE Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

CME

CME Group

$213.11

0.08 (0.04%)

, NDAQ

Nasdaq

$98.69

0.32 (0.33%)

06:26
10/21/19
10/21
06:26
10/21/19
06:26
Recommendations
CME Group, Nasdaq analyst commentary  »

Citi reiterates Buy on…

CME

CME Group

$213.11

0.08 (0.04%)

NDAQ

Nasdaq

$98.69

0.32 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 19

    Nov

BA

Boeing

$344.09

-25.04 (-6.78%)

06:25
10/21/19
10/21
06:25
10/21/19
06:25
Periodicals
Boeing board meets in Texas amid intensifying scrutiny, Reuters reports »

Boeing's board met…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

RES

RPC, Inc.

$4.61

0.065 (1.43%)

06:21
10/21/19
10/21
06:21
10/21/19
06:21
Upgrade
RPC, Inc. rating change  »

RPC, Inc. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

GOLD

Barrick Gold

$17.20

0.095 (0.56%)

06:20
10/21/19
10/21
06:20
10/21/19
06:20
Hot Stocks
Barrick Gold preparing to restart gold mining in Tanzania »

The government of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:19
10/21/19
10/21
06:19
10/21/19
06:19
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTE

DTE Energy

$127.38

-2.11 (-1.63%)

06:19
10/21/19
10/21
06:19
10/21/19
06:19
Upgrade
DTE Energy rating change  »

DTE Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 10

    Nov

  • 10

    Nov

  • 10

    Nov

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:19
10/21/19
10/21
06:19
10/21/19
06:19
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$67.62

-0.53 (-0.78%)

06:18
10/21/19
10/21
06:18
10/21/19
06:18
Periodicals
Exxon Mobil climate-change accounting case heads to court, WSJ reports »

Exxon Mobil Corp. and New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

COMM

CommScope

$11.56

-0.06 (-0.52%)

06:16
10/21/19
10/21
06:16
10/21/19
06:16
Upgrade
CommScope rating change  »

Nomura upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

  • 09

    Dec

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:16
10/21/19
10/21
06:16
10/21/19
06:16
Initiation
Peloton initiated  »

Peloton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:16
10/21/19
10/21
06:16
10/21/19
06:16
Initiation
Peloton initiated  »

Peloton initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:14
10/21/19
10/21
06:14
10/21/19
06:14
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:14
10/21/19
10/21
06:14
10/21/19
06:14
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$15.36

0.16 (1.05%)

06:13
10/21/19
10/21
06:13
10/21/19
06:13
Upgrade
HP Enterprise rating change  »

HP Enterprise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 09

    Dec

CBS

CBS

$36.75

-1 (-2.65%)

, VIAB

Viacom

$22.05

-0.56 (-2.48%)

06:12
10/21/19
10/21
06:12
10/21/19
06:12
Recommendations
CBS, Viacom analyst commentary  »

Barclays cuts CBS target…

CBS

CBS

$36.75

-1 (-2.65%)

VIAB

Viacom

$22.05

-0.56 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

SXT

Sensient

$60.17

-6.4 (-9.61%)

06:11
10/21/19
10/21
06:11
10/21/19
06:11
Downgrade
Sensient rating change  »

Sensient downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTON

Peloton

$23.44

-0.41 (-1.72%)

06:07
10/21/19
10/21
06:07
10/21/19
06:07
Initiation
Peloton initiated  »

Peloton initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPRT

Oportun Financial

$15.89

-0.22 (-1.37%)

06:06
10/21/19
10/21
06:06
10/21/19
06:06
Initiation
Oportun Financial initiated  »

Oportun Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$5.35

0.12 (2.29%)

06:06
10/21/19
10/21
06:06
10/21/19
06:06
Hot Stocks
Universal Technical CEO Kimberly McWaters to retire, Jerome Grant to succeed »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPE

Callon Petroleum

$3.83

-0.25 (-6.13%)

06:05
10/21/19
10/21
06:05
10/21/19
06:05
Hot Stocks
Callon Petroleum sees Q3 production 37.5-37.9 Mboed »

Callon Petroleum provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

AXNX

Axonics

$20.43

0.01 (0.05%)

06:04
10/21/19
10/21
06:04
10/21/19
06:04
Initiation
Axonics initiated  »

Axonics initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

RUHN

Ruhnn

$4.90

0.4 (8.89%)

, RDVT

Red Violet

$14.38

-0.09 (-0.62%)

06:03
10/21/19
10/21
06:03
10/21/19
06:03
Hot Stocks
Ruhnn appoints Jacky Jinbo Wang as new CFO »

Ruhnn (RUHN) has…

RUHN

Ruhnn

$4.90

0.4 (8.89%)

RDVT

Red Violet

$14.38

-0.09 (-0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.